Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Pcr Trastuzumab'

Pcr Trastuzumab published presentations and documents on DocSlides.

Managing Breast Cancer in the Genomic Era

Managing Breast Cancer in the Genomic Era

  • alida-meadow
  • 42 Slides

Leisha. A. . Emens. , M.D., . Ph.D. Associate Pr...

MUGA scans

MUGA scans

  • danika-pritchard
  • 50 Slides

&. monitoring of chemotherapy. Cardiovascular...

Fast relapsing

Fast relapsing

  • danika-pritchard
  • 2 Slides

patients . i.e. Patient relapses during or within...

New Therapies for Metastatic Breast Cancer

New Therapies for Metastatic Breast Cancer

  • alexa-scheidler
  • 70 Slides

Sigrun Hallmeyer, MD. Oncology Specialists, SC. D...

Metastatic HER2-Positive Breast Cancer: Treatment Selection

Metastatic HER2-Positive Breast Cancer: Treatment Selection

  • test
  • 25 Slides

First . Line and Beyond. Moderator:. Joseph Gligo...

Breast Cancer Highlights From San Antonio

Breast Cancer Highlights From San Antonio

  • tatyana-admore
  • 99 Slides

Joyce O'Shaughnessy, MD. Kimberly Blackwell, MD. ...

William J.

William J.

  • tawny-fly
  • 6 Slides

Gradishar. . MD, FACP. Betsy . Bramsen. Profess...

update in metastatic breast c

update in metastatic breast c

  • min-jolicoeur
  • 27 Slides

. Dr.Mina. . Tajvidi. Radiation . oncologist. ...

ID DB06366 CATEGORY

ID DB06366 CATEGORY

  • luanne-stotts
  • 0 Slides

Monoclonal antibodies . PERTUZUMAB . 148 . kDa. ...

Systemic Therapy for Breast Cancer

Systemic Therapy for Breast Cancer

  • natalia-silvester
  • 0 Slides

Adjuvant or Neoadjuvant. Agustin A Garcia, MD, MM...

Updates in the Treatment of Breast cancer

Updates in the Treatment of Breast cancer

  • alexa-scheidler
  • 0 Slides

Mohammad . Jahanzeb. , MD, FACP. Professor of Cli...

Neoadjuvant Target Therapy in Her-2 Positive Breast Cancer

Neoadjuvant Target Therapy in Her-2 Positive Breast Cancer

  • faustina-dinatale
  • 0 Slides

Dr. . Khaled Abulkhair, PhD. Medical Oncology SCE...

Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings

Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings

  • marina-yarberry
  • 68 Slides

Management of HER2 Over-Expressed Breast Cancer i...

Eribulin Mesylate + Trastuzumab

Eribulin Mesylate + Trastuzumab

  • easyho
  • 10 Slides

as First-Line Therapy for Locally Recurrent or . M...

Module 9: HER2-Positive and

Module 9: HER2-Positive and

  • norah
  • 38 Slides

Triple-Negative Breast Cancer. Jamie Carroll, APRN...

Part B Medical Drugs Requiring Step

Part B Medical Drugs Requiring Step

  • udeline
  • 1 Slides

-TherapyDrug subject to Step TherapyTry these Opti...

Part B Medical Drugs Requiring StepTherapy

Part B Medical Drugs Requiring StepTherapy

  • natalie
  • 1 Slides

Drug subject to Step Therapy BRAND NAME GENERIC NA...

Dawid Sigorski, Ph.D .

Dawid Sigorski, Ph.D .

  • morgan
  • 65 Slides

Department. of . oncology. . UWM. Epidemiology. ...

Budget impact and cost-effectiveness of oncology

Budget impact and cost-effectiveness of oncology

  • roxanne
  • 14 Slides

biosimilars. Prof. dr. Steven Simoens. Health econ...

Cost Impact Of Biosimiliars in Oncology

Cost Impact Of Biosimiliars in Oncology

  • williams
  • 29 Slides

Mansoor A Khan, BS, MS, BCOP. Senior Clinical Phar...

DRUG NAMES AND MEDICATION ERRORS

DRUG NAMES AND MEDICATION ERRORS

  • freya
  • 13 Slides

1. DRUG NAMES. Chemical name. Development name use...

HER2 positive breast carcinoma in the pre and post adjuvant anti-HER-2 therapy era: a single academ

HER2 positive breast carcinoma in the pre and post adjuvant anti-HER-2 therapy era: a single academ

  • carny
  • 14 Slides

Heather M. Gage, MD, Avanti . Rangnekar. , Robert ...

Breast Cancer in Older Patients

Breast Cancer in Older Patients

  • ButterflyKisses
  • 51 Slides

Key Issues. Etienne GC . Brain. , MD . PhD. Instit...

CoclusteringofErbB1andErbB2RevealedbyFRETSensitizedAcceptorBleachingg

CoclusteringofErbB1andErbB2RevealedbyFRETSensitizedAcceptorBleachingg

  • cora
  • 10 Slides

SubmittedDecember10,2009,andacceptedforpublication...

Antibody–Drug Conjugates in Development for Non-

Antibody–Drug Conjugates in Development for Non-

  • elizabeth
  • 49 Slides

s. mall Cell . Lung Cancer. , Gastric Cancer, and ...

Antibody–Drug Conjugates

Antibody–Drug Conjugates

  • wang
  • 55 Slides

in Development for . Breast Cancer. Sara A. Hurvit...

Antibody–Drug Conjugates: Practical Considerations and Applications in Clinical Use

Antibody–Drug Conjugates: Practical Considerations and Applications in Clinical Use

  • gelbero
  • 35 Slides

Sara A. Hurvitz, MD, FACP. Professor of Medicine. ...

Risk of Heart Failure in Breast Cancer Patients After

Risk of Heart Failure in Breast Cancer Patients After

  • sophia2
  • 27 Slides

Anthracycline. and . Trastuzumab. Treatment: A R...

Her2 + Breast Cancer Laura

Her2 + Breast Cancer Laura

  • ximena
  • 32 Slides

Bidstrup. Mrs B is a 49 . yo. woman who attended ...

Advanced Breast Cancer 31 year old female px severe pain right UL ‘burning’ pain

Advanced Breast Cancer 31 year old female px severe pain right UL ‘burning’ pain

  • margaret
  • 70 Slides

Background of lower back pain for 3/12 . No past ...

Module 9: HER2-Positive and Triple-Negative BC

Module 9: HER2-Positive and Triple-Negative BC

  • unita
  • 59 Slides

Percent with Patients. Number of Patients (Median)...

GIULIANA D’AURIA UOC Oncologia ASL Roma 2

GIULIANA D’AURIA UOC Oncologia ASL Roma 2

  • hadley
  • 50 Slides

Osp. . Pertini-S.Eugenio-CTO. Therapeutic. . app...

Mauricio Lema Medina – Clínica de Oncología Astorga / Clínica SOMA, Medellín

Mauricio Lema Medina – Clínica de Oncología Astorga / Clínica SOMA, Medellín

  • delcy
  • 117 Slides

Trastuzumab-emtansine. : A . very. . nice. . poi...

Metastatic triple-positive

Metastatic triple-positive

  • marcos147
  • 59 Slides

breast. . cancer. . needs. . different. . ther...

Copyright © 2024 DocSlides. All Rights Reserved